Multidrug-Resistant Organism Infections of Inpatients in a Hospital in Eastern China from 2015 to 2021

References

• Al-Tawfiq JA, Tambyah PA. Healthcare associated infections (HAI) perspectives. J Infect Public Health. 2014;7(4):339–344. doi:10.1016/j.jiph.2014.04.003
   PubMed Web of Science ®Google Scholar
• Klevens RM, Edwards JR, Richards CJ, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160–166. doi:10.1177/003335490712200205
   PubMed Web of Science ®Google Scholar
• Tchouaket NE, Beogo I, Sia D, et al. Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: systematic review using a discounting approach. J Hosp Infect. 2020;106(1):134–154. doi:10.1016/j.jhin.2020.07.004
   PubMed Web of Science ®Google Scholar
• Song TT, Li YT, Du JG, Meng W, Wang SH. Assessment of economic burden of stroke surgery patients due to nosocomial infection based on marginal analysis. Chin J Nosocomiol. 2020;30(06):888–892. doi:10.11816/cn.ni.2020-193169
   Google Scholar
• Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22(5):416–422. doi:10.1016/j.cmi.2015.12.002
   PubMed Web of Science ®Google Scholar
• Wen R, Li X, Liu T, Lin G. Effect of a real-time automatic nosocomial infection surveillance system on hospital-acquired infection prevention and control. BMC Infect Dis. 2022;22(1):857. doi:10.1186/s12879-022-07873-7
   PubMed Web of Science ®Google Scholar
• Du M, Xing Y, Suo J, et al. Real-time automatic hospital-wide surveillance of nosocomial infections and outbreaks in a large Chinese tertiary hospital. BMC Med Inform Decis. 2014;14(1):9. doi:10.1186/1472-6947-14-9
   PubMedGoogle Scholar
• National Health Commission of the People‘s Republic of China. Diagnostic criteria for healthcare-associated infection (trial). Natl Med J Chin. 2001;05:61–67.
   Google Scholar
• Raoofi S, Pashazadeh KF, Rafiei S, et al. Global prevalence of nosocomial infection: a systematic review and meta-analysis. PLoS One. 2023;18(1):e274248. doi:10.1371/journal.pone.0274248
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang YH, Hu YH, Zhang YQ. Characteristics and risk factors of hospital infection in a tertiary hospital in Suzhou, Jiangsu, from 2018 to 2020. Henan J Prev Med. 2022;33(05):355–358. doi:10.13515/j.cnki.hnjpm.1006-8414.2022.05.009
   Google Scholar
• Wu PY, Yang CX, Du YY, Wang Q. A study on the prevalence rate and influencing factors of nosocomial infection in a tertiary hospital from 2015–2021. J Prev Med Inf. 2022;38(03):400–405.
   Google Scholar
• Qu XJ, Chen YL, Liu Y, Fang XM. Current situation of nosocomial infection in a tertiary level-A hospital from 2015 to 2019. Chin J Disinfect. 2022;39(12):921–924. doi:10.11726/j.issn.1001-7658.2022.12.013
   Google Scholar
• Jiang XJ, Lv M, Sun JH. Analysis of nosocomial infection in a general hospital from 2016–2021. Chin J Hosp Stat. 2022;29(04):253–256. doi:10.3969/j.issn.1006-5253.2022.04.003
   Google Scholar
• Li SW, Jin YY, Liu YS, Cheng LL, Zhang XY. Survey of prevalence rates of nosocomial infections in a tertiary three-A hospital from 2021 to 2020. Chin J Nosocomiol. 2021;31(22):3474–3478. doi:10.11816/cn.ni.2021-211018
   Google Scholar
• Ketata N, Ben AH, Ben HM, et al. Point prevalence survey of health-care associated infections and their risk factors in the tertiary-care referral hospitals of Southern Tunisia. Infect Dis Health. 2021;26(4):284–291. doi:10.1016/j.idh.2021.06.004
   PubMed Web of Science ®Google Scholar
• Nair A, Steinberg WJ, Habib T, Saeed H, Raubenheimer JE. Prevalence of healthcare-associated infection at a tertiary hospital in the Northern Cape Province, South Africa. S Afr Fam Pract. 2018;60(5):162–167. doi:10.1080/20786190.2018.1487211
   Web of Science ®Google Scholar
• Mpinda-Joseph P, Anand Paramadhas BD, Reyes G, et al. Healthcare-associated infections including neonatal bloodstream infections in a leading tertiary hospital in Botswana. Hosp Pract. 2019;47(4):203–210. doi:10.1080/21548331.2019.1650608
   PubMedGoogle Scholar
• Sadeghi DA, Taati MM, Satarzadeh N. COVID-19 (Coronavirus Disease 2019): a new coronavirus disease. Infect Drug Resist. 2020;13:2819–2828. doi:10.2147/IDR.S259279
   PubMed Web of Science ®Google Scholar
• Lai X, Wang X, Yang Q, et al. Will healthcare workers improve infection prevention and control behaviors as COVID-19 risk emerges and increases, in China? Antimicrob Resist Infect Control. 2020;9(1):83. doi:10.1186/s13756-020-00746-1
   PubMed Web of Science ®Google Scholar
• Wu W, Wang W, Yuan Y, et al. Knowledge, attitude and practice concerning healthcare-associated infections among healthcare workers in Wuhan, China: cross-sectional study. BMJ Open. 2021;11(1):e42333. doi:10.1136/bmjopen-2020-042333
   Web of Science ®Google Scholar
• Shu MH, Huang WZ. Trend of prevalence rate of nosocomial infection in West China Hospital of Sichuan University from 2012–2018. Chin J Evid Based Med. 2020;20(07):759–763. doi:10.7507/1672-2531.201902066
   Google Scholar
• Casarotta E, Bottari E, Vannicola S, et al. Antibiotic treatment of Acinetobacter baumannii superinfection in patients with SARS-CoV-2 infection admitted to intensive care unit: an observational retrospective study. Front Med. 2022;9:910031. doi:10.3389/fmed.2022.910031
   Web of Science ®Google Scholar
• De Benedetto I, Lupia T, Shbaklo N, et al. Prognostic evaluation of Acinetobacter baumannii ventilator-associated pneumonia in COVID-19. Infez Med. 2022;30(4):570–576. doi:10.53854/liim-3004-12
   PubMedGoogle Scholar
• Montrucchio G, Corcione S, Lupia T, et al. The burden of carbapenem-resistant Acinetobacter baumannii in ICU COVID-19 patients: a regional experience. J Clin Med. 2022;11(17):5208. doi:10.3390/jcm11175208
   PubMed Web of Science ®Google Scholar
• Canturan SY, Yilmazer N, Sarikaya R, Avsar Z, Ertek M, Uyaner I. Retrospective assessment of ventilator-associated Pneumonias due to Acinetobacter baumannii in an oncology hospital. Sisli Etfal Hastan Tip Bul. 2021;55(2):193–196. doi:10.14744/SEMB.2021.01700
   PubMed Web of Science ®Google Scholar
• Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ Infectious diseases society of America guidance on the treatment of AmpC β-lactamase–producing enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections. Clin Infect Dis. 2021;74(12):2089–2114. doi:10.1093/cid/ciab101
   Web of Science ®Google Scholar
• Sumardika W, Cokro F, Suranadi W, Pinatih KJP. Multidrug-resistant organism infections correlate with increased mortality in COVID-19 patients: a retrospective, observational cohort study. Bali J Anesthesiol. 2022;6(4):231. doi:10.4103/bjoa.bjoa_181_22
   Google Scholar